29 Results for "

(-)-Apomorphine

" in MedChemExpress (MCE) Product Catalog:
Products (29)

29 Results for "(-)-Apomorphine" in MCE Product Catalog:

13
13 Publications Verification
Cat. No.: HY-16996A
CAS No.: 138356-21-5
Target:  

Sigma Receptor

Research Areas:  

Neurological Disease

BD-1047 dihydrobromide is a selective functional antagonist of sigma receptors. BD-1047 dihydrobromide attenuates Apomorphine (HY-12723)-induced climbing and Phencyclidine-induced head twitches .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N6973
CAS No.: 476-70-0
Boldine is an apomorphine isoquinoline alkaloid extracted from the root of the pheasant pepper (Litsea cubeba). Boldine is an oral effective antioxidant, anti-inflammatory, antitumor agent, and can inhibit osteoclast formation. Boldine induces apoptosis of human bladder cancer cells by regulating ERK, AKT and GSK-3β. Boldine ameliorates bone destruction by down-regulating the OPG/RANKL/RANK signaling pathway. It can be used in rheumatoid arthritis research .
loading...
    loading...
Cat. No.: HY-B1017
CAS No.: 15622-65-8
Synonyms: EN-1733A
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Molindone hydrochloride (EN-1733A) is an orally active and brain-penetrant dopamine D2/D5 receptor antagonist. Molindone hydrochloride shows antipsychotic and antidepressant-like activities. Molindone hydrochloride suppresses spontaneous locomotion, and antagonizes apomorphine-induced emesis. Molindone hydrochloride can be used for the research of neurological disease .
loading...
    loading...
Cat. No.: HY-119468
CAS No.: 32359-34-5
Purity:  99.34%
Target:  

Dopamine Transporter

Research Areas:  

Neurological Disease

Medifoxamine is an orally active monoamine reuptake inhibitor and antidepressant. Medifoxamine preferentially inhibits presynaptic dopamine reuptake. Medifoxamine acts as an intraocular pressure-lowering agent to reduce intraocular pressure, and also functions as a miotic agent to decrease pupil diameter. Medifoxamine exhibits characteristic properties of antidepressant compounds, including preventing hypothermia induced by Reserpine (HY-N0480) or Apomorphine (HY-12723), potentiating the toxic effects of Yohimbine (HY-N0127) in mice, and reducing immobility behavior in mice and rats in the "behavioral despair" model. Medifoxamine has no anticholinergic activity. Medifoxamine can be used in research related to depression .
loading...
    loading...
Cat. No.: HY-W648166
CAS No.: 1032714-06-9
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Dopamine D2 receptor antagonist-3 (Example 17) is an orally active and selective dopamine D2 receptor antagonist with a pIC50 of 5.52. Dopamine D2 receptor antagonist-3 exhibits antipsychotic activity in the Apomorphine (HY-12723) induced agitation in rats. Dopamine D2 receptor antagonist-3 can be used for psychiatric and neurological disorders research .
loading...
    loading...
Cat. No.: HY-19372
CAS No.: 223502-85-0
Research Areas:  

Neurological Disease

SSR-181507 hydrochloride is a dopamine D2 receptor antagonist and 5-HT1A receptor agonist. SSR-181507 antagonizes Apomorphine (HY-12723)-induced climbing in mice and stereotypies in rats. SSR-181507 hydrochloride can be used in the research of depression and anxiety .
loading...
    loading...
Cat. No.: HY-106781
CAS No.: 111073-34-8
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

OPC-4392 is a orally active presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist. OPC 4392 reverses the Reserpine (HY-N0480)-induced dopamine accumulation, inhibits Apomorphine (HY-12723)-induced stereotypic and climbing behaviors in mouse models. OPC-4392 can be used as antipsychotic agent .
loading...
    loading...
Cat. No.: HY-W726429
CAS No.: 76787-63-8
Synonyms: (-)-Apomorphine hydrochloride-d4
Apomorphine hydrochloride-d4 ((-)-Apomorphine hydrochloride-d4) is the deuterium labeled Apomorphine hydrochloride.
loading...
    loading...
Cat. No.: HY-19019
CAS No.: 124842-93-9
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Y-20024 hydrochloride is an orally active D2 receptor antagonist with blood-brain barrier permeability. Y-20024 hydrochloride can inhibit Apomorphine (HY-12723)-induced ADHD in mice. Y-20024 hydrochloride can inhibit Apomorphine-induced vomiting in dogs. Y-20024 hydrochloride has prolactin-promoting activity. Y-20024 hydrochloride can be used in research on neurological disorders such as ADHD and vomiting .
loading...
    loading...
Cat. No.: HY-119595
CAS No.: 2924-46-1
Synonyms: R3201
Target:  

Others

Research Areas:  

Neurological Disease

Haloperidide (R3201) is a neuroleptic compound. Haloperidide is a potent and selective anti-emetic agent. Haloperidide antagonizes Apomorphine (HY-12723)-induced emesis in dogs .
loading...
    loading...
Cat. No.: HY-16996
CAS No.: 138356-20-4
Target:  

Sigma Receptor

Research Areas:  

Neurological Disease

BD-1047 is a selective functional antagonist of sigma receptors. BD-1047 attenuates Apomorphine (HY-12723)-induced climbing and Phencyclidine-induced head twitches .
loading...
    loading...
Cat. No.: HY-120076
CAS No.: 179089-90-8
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

CP-293019 is a dopamine D4 receptor antagonist, with a Ki value of 3.4 nM. CP-293019 can inhibit Apomorphine (HY-12723) induced hyperactivity in rats .
loading...
    loading...
Cat. No.: HY-121100
CAS No.: 305339-41-7
Purity:  99.81%
Target:  

iGluR

Research Areas:  

Neurological Disease

BZAD-01 is a potent, selective and orally active inhibitor of NMDA NR2B subunit, with a Ki of 72 nM. BZAD-01 can improve postural asymmetry as well as Apomorphine-induced rotation .
loading...
    loading...
Cat. No.: HY-W151617A
CAS No.: 329218-14-6
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Desethoxy Quetiapine dihydrochloride (Compound 28) is an antagonist for dopamine D2 receptor with an IC50 of 1330 nM. Desethoxy Quetiapine dihydrochloride antagonises Apomorphine (HY-12723)-induced climbing and swimming disruption in mouse models .
loading...
    loading...
Cat. No.: HY-B1573A
CAS No.: 36504-94-6
Synonyms: AY-23,028; dl-Butaclamol hydrochloride
(±)-Butaclamol hydrochloride (AY-23,028) is the antagonist for adrenergic receptor and dopamine receptor. (±)-Butaclamol hydrochloride antagonizes amphetamine or Apomorphine (HY-12723)-induced stereotyped behaviors and emesis, inhibits discriminative avoidance behavior, and induces catalepsy in rats models .
loading...
    loading...
Cat. No.: HY-106781A
CAS No.: 1329509-60-5
Purity:  98.99%
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

OPC 4392 hydrochloride is an agonist for presynaptic dopamine receptor and an antagonist for postsynaptic D2 receptor. OPC 4392 reverses the Reserpine (HY-N0480)-induced dopamine accumulation, inhibits Apomorphine (HY-12723)-induced stereotypic and climbing behaviors in mouse models .
loading...
    loading...
Cat. No.: HY-115895
CAS No.: 23915-73-3
Synonyms: CI-686 free base
Trebenzomine (CI-686 free base) is a centrally acting psychotropic compound. Trebenzomine has both neuroleptic and stimulant activity. Trebenzomine potentiates Methamphetamine-induced self-stimulation. Trebenzomine reduces septal hyperirritability, suppression of conditioned avoidance behavior, blocks Apomorphine (HY-12723)-induced emesis in dogs .
loading...
    loading...
Cat. No.: HY-16996AR
CAS No.: 138356-21-5
Target:  

Sigma Receptor

Research Areas:  

Neurological Disease

BD-1047 (dihydrobromide) (Standard) is the analytical standard of BD-1047 (dihydrobromide). This product is intended for research and analytical applications. BD-1047 dihydrobromide is a selective functional antagonist of sigma receptors. BD-1047 dihydrobromide attenuates Apomorphine (HY-12723)-induced climbing and Phencyclidine-induced head twitches .
loading...
    loading...
Cat. No.: HY-108985
CAS No.: 97110-59-3
Synonyms: EGYT-3615
Target:  

Others

Research Areas:  

Neurological Disease

Trazium esilate (EGYT-3615) is an antidepressant, which influences the central dopaminergic system. Trazium esilate synergizes amphetamine, potentiates stereotypy and hypermotility. Trazium esilate blocks Apomorphine (HY-12723)-induced hypothermic and the stereotypy, and Bulbocapnine (HY-W436270)-induced cataleptic state. Trazium esilate enhances the effect of Norepinephrine (HY-13715) on isolated vas deferens of the rat .
loading...
    loading...
Cat. No.: HY-106194
CAS No.: 264869-71-8
SLV310 is an orally active dopamine D2 receptor antagonist (Ki: 5 nM) and serotonin reuptake receptor inhibitor. SLV310 antagonizes Apomorphine (HY-12723) induced climbing behaviour and 5-HTP (HY-N0122) induced serotonin syndrome like behaviour in mice (ED50: 5.6 and 5.9 mg/kg, p.o.). SLV310 is an antipsychotic compound and can be used for schizophrenia research .
loading...
    loading...